Production (Stage)
Biocure Technology Inc.
BICTF
$0.01
$0.0086614.29%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 85.61% | -346.70% | -385.29% | -0.27% | -18.52% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -99.41% | 255.78% | 260.74% | 170.98% | 992.96% |
| Change in Net Operating Assets | 3.09% | -55.37% | -58.93% | -51.88% | -50.33% |
| Cash from Operations | 106.34% | 115.91% | 112.49% | 105.66% | 74.89% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | -100.00% | -80.05% | -43.59% |
| Cash from Investing | -- | -100.00% | -100.00% | -80.05% | -43.59% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.93% | -100.77% | -102.71% | -70.30% |
| Cash from Financing | -- | -115.46% | -112.64% | -116.93% | -78.80% |
| Foreign Exchange rate Adjustments | -- | -100.00% | -100.00% | -100.00% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 141.13% | 148.15% | 127.51% | 89.09% | 73.45% |